Cite
Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma.
MLA
Jiang, Hongmei, et al. “Posttranslational Modification of Aurora A‐NSD2 Loop Contributes to Drug Resistance in t(4;14) Multiple Myeloma.” Clinical & Translational Medicine, vol. 12, no. 4, Apr. 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1002/ctm2.744.
APA
Jiang, H., Wang, Y., Wang, J., Wang, Y., Wang, S., He, E., Guo, J., Xie, Y., Wang, J., Li, X., Peng, Z., Wang, M., Hou, J., & Liu, Z. (2022). Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma. Clinical & Translational Medicine, 12(4), 1–16. https://doi.org/10.1002/ctm2.744
Chicago
Jiang, Hongmei, Yixuan Wang, Jingjing Wang, Yafei Wang, Sheng Wang, Enyang He, Jing Guo, et al. 2022. “Posttranslational Modification of Aurora A‐NSD2 Loop Contributes to Drug Resistance in t(4;14) Multiple Myeloma.” Clinical & Translational Medicine 12 (4): 1–16. doi:10.1002/ctm2.744.